Jinxin Fertility Group Inkomsten in het verleden

Verleden criteriumcontroles 4/6

De winst van Jinxin Fertility Group is gedaald met een gemiddeld jaarlijks percentage van -6.3%, terwijl de winst van de Healthcare -industrie jaarlijks groeide met 9%. De inkomsten zijn groeide met een gemiddeld percentage van 16.5% per jaar. Het rendement op het eigen vermogen Jinxin Fertility Group bedraagt 3.1% en de nettomarge bedraagt 10.7%.

Belangrijke informatie

-6.3%

Groei van de winst

-11.6%

Groei van de winst per aandeel

Healthcare Groei van de industrie	11.3%
Inkomstengroei	16.5%
Rendement op eigen vermogen	3.1%
Nettomarge	10.7%
Laatste winstupdate	30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Opbrengsten en kosten

Hoe Jinxin Fertility Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

SHSC:1951 Opbrengsten, kosten en inkomsten (CNY Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Jun 24	2,899	311	700	22
31 Mar 24	2,844	328	687	22
31 Dec 23	2,789	345	673	22
30 Sep 23	2,675	250	659	23
30 Jun 23	2,560	155	644	23
31 Mar 23	2,462	138	627	20
31 Dec 22	2,364	121	610	17
30 Sep 22	2,241	248	535	14
30 Jun 22	2,118	374	460	10
31 Mar 22	1,978	357	425	11
31 Dec 21	1,839	340	389	11
30 Sep 21	1,756	316	382	11
30 Jun 21	1,674	291	376	12
31 Mar 21	1,550	271	346	12
31 Dec 20	1,426	252	317	11
30 Sep 20	1,448	304	301	12
30 Jun 20	1,469	356	286	12
31 Mar 20	1,559	383	280	13
31 Dec 19	1,648	410	274	13
30 Sep 19	1,475	339	220	13
30 Jun 19	1,301	269	166	12
31 Mar 19	1,112	218	135	12
31 Dec 18	922	167	103	12
31 Dec 17	663	99	60	10
31 Dec 16	346	88	26	0

Kwaliteitswinsten: 1951 heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (10.7%) 1951 } zijn hoger dan vorig jaar (6%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van 1951 is de afgelopen 5 jaar met 6.3% per jaar gedaald.

Versnelling van de groei: De winstgroei van 1951 over het afgelopen jaar ( 101.1% ) overtreft het 5-jarig gemiddelde ( -6.3% per jaar).

Winst versus industrie: De winstgroei 1951 over het afgelopen jaar ( 101.1% ) overtrof de Healthcare -sector -16.9%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 3.1% ) van 1951 wordt als laag beschouwd.

Jinxin Fertility Group Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

First half 2024 earnings released: EPS: CN¥0.071 (vs CN¥0.084 in 1H 2023)

Jinxin Fertility Group Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022)

Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022)

Jinxin Fertility Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

First half 2023 earnings released: EPS: CN¥0.084 (vs CN¥0.076 in 1H 2022)

Recent updates

Investor sentiment deteriorates as stock falls 25%

Investor sentiment improves as stock rises 18%

First half 2024 earnings released: EPS: CN¥0.071 (vs CN¥0.084 in 1H 2023)

Jinxin Fertility Group Limited to Report First Half, 2024 Results on Aug 29, 2024

Investor sentiment deteriorates as stock falls 18%

Upcoming dividend of HK$0.059 per share

Investor sentiment improves as stock rises 15%

Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022)

Jinxin Fertility Group Limited, Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022)

Jinxin Fertility Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 25 July 2024

Jinxin Fertility Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

Investor sentiment improves as stock rises 15%

Non-Executive Director recently bought HK$2.0m worth of stock

Co-CEO & Executive Director recently bought HK$3.6m worth of stock

Investor sentiment deteriorates as stock falls 17%

Jinxin Fertility Group Limited Announces Change of Chief Financial Officer

First half 2023 earnings released: EPS: CN¥0.084 (vs CN¥0.076 in 1H 2022)

Jinxin Fertility Group Limited to Report First Half, 2023 Results on Aug 29, 2023

Co-CEO & Executive Director recently bought HK$7.8m worth of stock

Full year 2022 earnings released: EPS: CN¥0.049 (vs CN¥0.14 in FY 2021)

Investor sentiment deteriorates as stock falls 18%

Now 23% undervalued

Jinxin Fertility Group Limited has completed a Follow-on Equity Offering in the amount of HKD 1.176875 billion.

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Chairman of the Board recently bought HK$6.5m worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First half 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.063 in 1H 2021)

Jinxin Fertility Group Limited to Report First Half, 2022 Results on Aug 31, 2022

Jinxin Fertility Group Limited Declares Final Dividend for the Year Ended December 31, 2021

Investor sentiment improved over the past week

Upcoming dividend of HK$0.074 per share

Investor sentiment improved over the past week

Jinxin Fertility Group Limited, Annual General Meeting, Jun 28, 2022

CO-CEO & Executive Director recently bought HK$15m worth of stock

Full year 2021 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in FY 2020)

Jinxin Fertility Group Limited Proposes Final Dividend for the Year Ended December 31, 2021, Payable on July 22, 2022

Investor sentiment deteriorated over the past week

CEO & Executive Director recently bought HK$1.9m worth of stock

CEO & Executive Director recently bought HK$1.0m worth of stock

First half 2021 earnings released: EPS CN¥0.063 (vs CN¥0.048 in 1H 2020)

Independent Non-Executive Director Haw Kuang Lim has left the company

Joint Company Secretary Suet Wing Leung has left the company

CEO & Executive Director recently bought HK$6.2m worth of stock

Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.19 in FY 2019)

Chairman of the Board Bin Wang has left the company

Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.19 in FY 2019)

Jinxin Fertility Group Limited to Report Q4, 2020 Results on Mar 28, 2021

New 90-day high: HK$19.40

New 90-day high: HK$17.22

New 90-day high: HK$15.80

New 90-day high: HK$15.04

Market bids up stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: HK$11.80

New 90-day low: HK$9.65

First half earnings released

New 90-day low: HK$9.76

First half earnings released

Jinxin Fertility Group Limited to Report First Half, 2020 Results on Aug 31, 2020

Jinxin Fertility Group Limited Announces Management Changes

Opbrengsten en kosten

Inkomsten en omzetgeschiedenis